Lene Ryom - Infectious Diseases

Author Information

Lene Ryom is a distinguished researcher associated with the Department of Infectious Diseases at the Centre of Excellence for Health, Immunity and Infections, Section 2100, Rigshospitalet, University of Copenhagen in Copenhagen, Denmark. Her work primarily focuses on the intersection of infectious diseases and public health, with a particular emphasis on HIV/AIDS and its broader health implications.

Research Contributions

Lene Ryom has made significant contributions to the field of infectious diseases, particularly in understanding the complexities of HIV treatment and its impact on broader health outcomes. Her recent work includes investigating the incidence of hypertension in people with HIV under different antiretroviral regimens, examining the prevalence and outcomes of pregnancies in women living with HIV, and exploring the risk factors for cardiovascular diseases and cancers among people living with HIV. Her research has been pivotal in guiding clinical practices, as evidenced by her involvement in the major revision of the European AIDS Clinical Society Guidelines 2021.

Aliases

Lene Ryom is also referenced in academic and research circles as L Ryom.

Publication and Citation Metrics

Metric	Value
Total Citations	3768
h-index	29
Number of Papers	116

Publications:

Novel hepatitis B virus reverse transcriptase mutations in patients with sustained viremia despite long-term tenofovir treatment

DOI: 10.1016/j.jcv.2022.105159

Year: 2022

Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium.

DOI: 10.1111/hiv.13273

Year: 2022

Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021.

DOI: 10.1111/hiv.13268

Year: 2022

Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting

DOI: 10.1093/ofid/ofac029

Year: 2022

Cardiovascular risks associated with protease inhibitors for the treatment of HIV

DOI: 10.1080/14740338.2021.1935863

Year: 2021

Risk for Non–AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy

DOI: 10.7326/M20-5226

Year: 2021

Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States

DOI: 10.1002/jia2.25690

Year: 2021

Prevalence and outcomes of pregnancies in women living with HIV over a 20-year period: The EuroSIDA study, 1996 to 2015.

DOI: 10.1097/QAD.0000000000002954

Year: 2021

Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium.

DOI: 10.1016/S2352-3018(21)00163-6

Year: 2021

Uptake and discontinuation of integrase inhibitors (INSTIs) in a large cohort setting.

DOI: 10.1097/QAI.0000000000002250

Year: 2020

What are the symptoms of HIV?

What Measures Can Reduce the Spread of Respiratory Droplets?

Are There Any Complications?

What is Fatty Acid Biosynthesis?

How Do These Studies Impact Public Health?

What are the Challenges in Controlling Dengue Hemorrhagic Fever?

How Do Antimicrobial Resistance and Infectious Diseases Relate?

How Does a PCR Test Work?

How is HIV diagnosed?

How Can Aedes Aegypti Be Controlled?

Partnered Content Networks

Relevant Topics